Skip to main content
Key Specialties
Anesthesiology Cardiology Dermatology Diabetology Endocrinology Gastroenterology General Medicine Geriatrics Hematology Infectious Diseases Internal Medicine Nephrology Neurology Obstetrics and Gynecology Oncology Pediatrics Psychiatry Radiology Respiratory Medicine Rheumatology Surgery Urology
Congress Coverage
2024 ESMO Congress 2024 ERS Congress 2024 EASD Congress 2024 ESC Congress 2024 EAN Congress 2024 ASCO Annual Meeting 2024 ACC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote series | Spotlight on menopause

Menopause can have a significant impact on the body, with effects ranging beyond the endocrine and reproductive systems. Learn about the systemic effects of menopause, so you can help patients in your clinics through the transition.

Launching: Thursday 12th December 2024
ADVANCED SEARCH
Log in
Top
Heart Failure Reviews

06-11-2024 | Cardiogenic Shock | Review

Adrenal crisis-induced cardiogenic shock (ACCS): a comprehensive review

Authors: Maryam Heidarpour, Davood Shafie, Reza Eshraghi, Seyed Reza Mirjalili, Ashkan Bahrami, Mohammad Reza Movahed

Published in: Heart Failure Reviews

Login to get access

Abstract

Adrenal insufficiency (AI) is a disorder in which inadequate glucocorticoid and mineralocorticoid hormone production leads to a variety of symptoms, including fatigue, weight loss, and nausea. In some patients with unknown AI, adrenal crisis-induced cardiogenic shock (ACCS) can be the first presentation, resulting in a fatal situation. The ACCS may exhibit unresponsiveness to inotropes and fluid therapy; thus, glucocorticoid administration is the primary vital intervention, making early detection of AI essential. Hence, in this study, we review the case reports demonstrating acute cardiomyopathies in the context of AI. The review addresses the suggested underlying mechanisms, including the diminished protective effects of glucocorticoids against catecholamines in AI. We also highlighted some clues to aid physicians in considering AI as a differential diagnosis in critically ill patients presenting cardiogenic shock.
Literature
1.
2.
Bleicken B, Ventz M, Quinkler M, Hahner S (2010) Delayed diagnosis of adrenal insufficiency is common: a cross-sectional study in 216 patients. Am J Med Sci 339(6):525–531PubMedCrossRef
3.
Upala S, Yong WC, Sanguankeo A (2016) Primary adrenal insufficiency misdiagnosed as hypothyroidism in a patient with polyglandular syndrome. N Am J Med Sci 8(5):226PubMedPubMedCentralCrossRef
4.
Betterle C, Presotto F, Furmaniak J (2019) Epidemiology, pathogenesis, and diagnosis of Addison’s disease in adults. J Endocrinol Investig 42(12):1407–1433CrossRef
5.
Chabre O, Goichot B, Zenaty D, Bertherat J (2017) Group 1. Epidemiology of primary and secondary adrenal insufficiency: prevalence and incidence, acute adrenal insufficiency, long-term morbidity and mortality. Ann Endocrinol (Paris) 78(6):490–494PubMedCrossRef
6.
Afreen B, Khan KA, Riaz A (2017) Adrenal insufficiency in Pakistani HIV infected patients. J Ayub Med Coll Abbottabad 29(3):428–431PubMed
7.
Erichsen MM, Løvås K, Skinningsrud B, Wolff AB, Undlien DE, Svartberg J et al (2009a) Clinical, immunological, and genetic features of autoimmune primary adrenal insufficiency: observations from a Norwegian registry. J Clin Endocrinol Metab 94(12):4882–4890PubMedCrossRef
8.
9.
Laureti S, Vecchi L, Santeusanio F, Falorni A (1999) Is the prevalence of Addison’s disease underestimated? J Clin Endocrinol Metab 84(5):1762PubMed
10.
Hellesen A, Bratland E, Husebye ES (eds) (2018) Autoimmune Addison's disease–an update on pathogenesis. Ann Endocrinol 79(3):157–163
11.
Mason AS, Meade T, Lee J, Morris J (1968) Epidemiological and clinical picture of Addison's disease. Lancet 292(7571):744–747CrossRef
12.
Olafsson AS, Sigurjonsdottir HA (2016) Increasing prevalence of Addison disease: results from a nationwide study. Endocr Pract 22(1):30–35PubMedCrossRef
13.
Miller FW (2023) The increasing prevalence of autoimmunity and autoimmune diseases: an urgent call to action for improved understanding, diagnosis, treatment, and prevention. Curr Opin Immunol 80:102266PubMedCrossRef
14.
15.
Bornstein SR, Allolio B, Arlt W, Barthel A, Don-Wauchope A, Hammer GD et al (2016a) Diagnosis and treatment of primary adrenal insufficiency: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 101(2):364–389PubMedCrossRef
16.
Dalin F, Nordling Eriksson G, Dahlqvist P, Hallgren Å, Wahlberg J, Ekwall O et al (2017) Clinical and immunological characteristics of autoimmune Addison disease: a nationwide Swedish multicenter study. J Clin Endocrinol Metab 102(2):379–389PubMed
17.
Reato G, Morlin L, Chen S, Furmaniak J, Smith BR, Masiero S et al (2011) Premature ovarian failure in patients with autoimmune Addison's disease: clinical, genetic, and immunological evaluation. J Clin Endocrinol Metab 96(8):E1255–E1E61PubMedCrossRef
18.
Lakhotia M, Pahadia HR, Kumar H, Singh J, Tak S (2015) A case of autoimmune polyglandular syndrome (APS) type II with hypothyroidism, hypoadrenalism, and celiac disease-a rare combination. J Clin Diagn Res 9(4):OD01PubMedPubMedCentral
19.
Prylutskyi O, Prylutska O, Degonskyi A, Tkachenko K (2016) A case of autoimmune polyglandular syndrome. Ype 2 associated with atypical form of Scleromyxedema. Ethiop J Health Sci 26(5):503PubMedPubMedCentral
20.
Collins S, Caron M, Lefkowitz R (1988a) Beta-adrenergic receptors in hamster smooth muscle cells are transcriptionally regulated by glucocorticoids. J Biol Chem 263(19):9067–9070PubMedCrossRef
21.
Orlowski J, Lingrel J (1990a) Thyroid and glucocorticoid hormones regulate the expression of multiple Na, K-ATPase genes in cultured neonatal rat cardiac myocytes. J Biol Chem 265(6):3462–3470PubMedCrossRef
22.
Stowasser M, Ahmed A, Pimenta E, Taylor P, Gordon R (2012) Factors affecting the aldosterone/renin ratio. Horm Metab Res 44(03):170–176PubMedCrossRef
23.
Stanton A (2003) Potential of renin inhibition in cardiovascular disease. J Renin-Angiotensin-Aldosterone Syst 4(1):6–10PubMedCrossRef
24.
Shen XZ, Xiao HD, Li P, Lin CX, Fuchs S, Bernstein KE (2008) Tissue specific expression of angiotensin converting enzyme: a new way to study an old friend. Int Immunopharmacol 8(2):171–176PubMedPubMedCentralCrossRef
25.
Atlas SA (2007) The renin-angiotensin aldosterone system: pathophysiological role and pharmacologic inhibition. J Manag Care Pharm 13(8 Supp B):9–20PubMed
26.
Bollag WB (2011) Regulation of aldosterone synthesis and secretion. Compr Physiol 4(3):1017–1055
27.
Otte C, Wüst S, Zhao S, Pawlikowska L, Kwok P-Y, Whooley MA (2010) Glucocorticoid receptor gene, low-grade inflammation, and heart failure: the heart and soul study. J Clin Endocrinol Metab 95(6):2885–2891PubMedCrossRef
28.
Oster H, Challet E, Ott V, Arvat E, de Kloet ER, Dijk D-J et al (2017) The functional and clinical significance of the 24-hour rhythm of circulating glucocorticoids. Endocr Rev 38(1):3–45PubMedCrossRef
29.
Henley D, Lightman S, Carrell R (2016) Cortisol and CBG—getting cortisol to the right place at the right time. Pharmacol Ther 166:128–135PubMedCrossRef
30.
Chan WL, Carrell RW, Zhou A, Read RJ (2013) How changes in affinity of corticosteroid-binding globulin modulate free cortisol concentration. J Clin Endocrinol Metab 98(8):3315–3322PubMedPubMedCentralCrossRef
31.
Navar LG, Kobori H, Prieto MC, Gonzalez-Villalobos RA (2011) Intratubular renin-angiotensin system in hypertension. Hypertension 57(3):355–362PubMedCrossRef
32.
Hahner S, Spinnler C, Fassnacht M, Burger-Stritt S, Lang K, Milovanovic D et al (2015) High incidence of adrenal crisis in educated patients with chronic adrenal insufficiency: a prospective study. J Clin Endocrinol Metab 100(2):407–416PubMedCrossRef
33.
Bergthorsdottir R, Leonsson-Zachrisson M, Odén A, Johannsson G (2006) Premature mortality in patients with Addison’s disease: a population-based study. J Clin Endocrinol Metab 91(12):4849–4853PubMedCrossRef
34.
Erichsen MM, Løvås K, Fougner KJ, Svartberg J, Hauge ER, Bollerslev J et al (2009b) Normal overall mortality rate in Addison's disease, but young patients are at risk of premature death. Eur J Endocrinol 160(2):233–237PubMedCrossRef
35.
Falhammar H, Frisén L, Norrby C, Hirschberg AL, Almqvist C, Nordenskjöld A, Nordenström A (2014) Increased mortality in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Clin Endocrinol Metab 99(12):E2715–E2E21PubMedCrossRef
36.
Allolio B (2015) Extensive expertise in endocrinology: adrenal crisis. Eur J Endocrinol 172(3):R115–RR24PubMedCrossRef
37.
Smans LC, Van der Valk ES, Hermus AR, Zelissen PM (2016) Incidence of adrenal crisis in patients with adrenal insufficiency. Clin Endocrinol 84(1):17–22CrossRef
38.
Hahner S, Loeffler M, Bleicken B, Drechsler C, Milovanovic D, Fassnacht M et al (2010) Epidemiology of adrenal crisis in chronic adrenal insufficiency: the need for new prevention strategies. Eur J Endocrinol 162(3):597–602PubMedCrossRef
39.
Okamoto M (1963) The metabolism of cortisol in hyperthyroidism and Cushing's syndrome. Endocrinol Jpn 10(3):159–168PubMedCrossRef
40.
Rushworth RL, Chrisp GL, Torpy DJ (2018) Glucocorticoid-induced adrenal insufficiency: a study of the incidence in hospital patients and a review of peri-operative management. Endocr Pract 24(5):437–445PubMedCrossRef
41.
Rushworth RL, Torpy DJ (2014) A descriptive study of adrenal crises in adults with adrenal insufficiency: increased risk with age and in those with bacterial infections. BMC Endocr Disord 14(1):1–8CrossRef
42.
Tompkins MG, Bissell BD, Sowders V, Kern PA (2020) Inclusion of adrenal crisis in the differential diagnosis of distributive shock. Am J Health Syst Pharm 77(6):415–417PubMedCrossRef
43.
Smith N, Lopez RA, Silberman M (2024) Distributive shock. StatPearls Publishing LLC, Treasure Island (FL)
44.
Wolff B, Machill K, Schulzki I, Schumacher D, Werner D (2007a) Acute reversible cardiomyopathy with cardiogenic shock in a patient with Addisonian crisis: a case report. Int J Cardiol 116(2):e71–e73PubMedCrossRef
45.
Harris CL, Khalid M, Hashmi A, Shani J, Malik BA (2021) A case of adrenal crisis-induced stress cardiomyopathy. Cureus 13(4):e14420PubMedPubMedCentral
46.
Conwell LS, Gray LM, Delbridge RG, Thomsett MJ, Batch JA (2003b) Reversible cardiomyopathy in paediatric Addison's disease a cautionary tale. J Pediatr Endocrinol Metab 16(8):1191–1195PubMedCrossRef
47.
Hyland KA, Altman DS, Perkins JM (2016b) Reversible heart failure as a result of newly diagnosed primary adrenal insufficiency. AACE Clin Case Rep 2(4):e321–e3e4CrossRef
48.
Ödek Ç, Kendirli T, Kocaay P, Azapağası E, Uçar T, Şıklar Z, Berberoğlu M (2017) Acute reversible cardiomyopathy and heart failure in a child with acute adrenal crisis. Paediatr Int Child Health 37(2):148–151PubMedCrossRef
49.
Wiltshire E, Wilson R, Pringle K (2004b) Addison's disease presenting with an acute abdomen and complicated by cardiomyopathy. J Paediatr Child Health 40(11):644–645PubMedCrossRef
50.
Derish M, Eckert K, Chin C (1996) Reversible cardiomyopathy in a child with Addison's disease. Intensive Care Med 22(5):460–463PubMedCrossRef
51.
Lohiya S, Subramanyam S, Ovalle F (2016) Cardiogenic shock: an initial presentation of primary adrenal insufficiency. AACE Clin Case Rep 2(3):e206–e2e9CrossRef
52.
Lüsebrink E, Krieg K, Massberg S, Orban M (2021b) Venoarterial extracorporeal membrane oxygenation as bridge to effective treatment in a 19-year-old woman with acute adrenal crisis: a case report. Eur Heart J-Case Rep 5(2):ytab031PubMedPubMedCentralCrossRef
53.
Wani AI, Farooqui KJ, Bashir MI, Mir SA, Lone AA, Masoodi SR (2013b) Autoimmune polyglandular syndrome type 1 with reversible dilated cardiomyopathy: complete recovery after correction of hypocalcemia and hypocortisolemia. J Pediatr Endocrinol Metab 26(3–4):373–376
54.
Huang D, Kreitler K, Tilton S, Cavarocchi NC, Hirose H (2019) Cardiogenic shock requiring extracorporeal membrane oxygenation support in a patient with Panhypopituitarism: a case report. Cureus 11(6):e4995PubMedPubMedCentral
55.
Karavelioglu Y, Baran A, Karapinar H, Küçükdurmaz Z, Yilmaz A (2013) Reversible cardiomyopathy associated with autoimmune polyendocrine syndrome type II. Intern Med 52(9):981–985PubMedCrossRef
56.
57.
Baranski Lamback E, Morandi G, Rapti E, Christov G, Brogan PA, Hindmarsh P (2018) Addison's disease presenting with perimyocarditis. Journal of Pediatric Endocrinology & Metabolism : JPEM 31(1):101–105CrossRef
58.
Krishnamoorthy A, Mentz RJ, Hyland KA, EB MM, Patel CB, Milano CA, Hernandez AF (2013) A crisis of the heart: an acute reversible cardiomyopathy bridged to recovery in a patient with Addison's disease. ASAIO Journal (American Society for Artificial Internal Organs : 1992) 59(6):668–670PubMedCrossRef
59.
Wolff B, Machill K, Schulzki I, Schumacher D, Werner D (2007b) Acute reversible cardiomyopathy with cardiogenic shock in a patient with Addisonian crisis: a case report. Int J Cardiol 116(2):e71–ee3PubMedCrossRef
60.
Khatiwada S, Singh B, Mandal L, Mittal R, Jaiswal R (2021) Heart failure with low ejection fraction as a presentation of severe primary adrenal insufficiency. J Chitwan Med Coll 11(3):141–144CrossRef
61.
Mekontso-Dessap A, Marrache D, Vieillard-Baron A (2005) Images in cardiology: acute adrenal insufficiency complicated by cardiogenic shock. Heart 91(4):e31PubMedPubMedCentralCrossRef
62.
Kang MS, Sandhu CS, Singh N, Evans T (2019b) Initiation of levothyroxine in a patient with hypothyroidism inducing adrenal crisis requiring VA ECMO: a tale of preventable disaster. BMJ Case Rep 12(8):e230601
63.
Hyland K, Altman D, Perkins J (2016a) Reversible heart failure as a result of newly diagnosed primary adrenal insufficiency. AACE Clin Case Rep 2:e321–e3e4CrossRef
64.
Kang MS, Sandhu CS, Singh N, Evans T (2019a) Initiation of levothyroxine in a patient with hypothyroidism inducing adrenal crisis requiring VA ECMO: a tale of preventable disaster. BMJ Case Rep 12(8)
65.
Lüsebrink E, Krieg K, Massberg S, Orban M (2021a) Venoarterial extracorporeal membrane oxygenation as bridge to effective treatment in a 19-year-old woman with acute adrenal crisis: a case report. Eur Heart J Case Rep 5(2):ytab031PubMedPubMedCentralCrossRef
66.
Collins S, Caron MG, Lefkowitz RJ (1988b) Beta-adrenergic receptors in hamster smooth muscle cells are transcriptionally regulated by glucocorticoids. J Biol Chem 263(19):9067–9070PubMedCrossRef
67.
Orlowski J, Lingrel JB (1990b) Thyroid and glucocorticoid hormones regulate the expression of multiple Na,K-ATPase genes in cultured neonatal rat cardiac myocytes. J Biol Chem 265(6):3462–3470PubMedCrossRef
68.
Nef HM, Möllmann H, Akashi YJ, Hamm CW (2010) Mechanisms of stress (Takotsubo) cardiomyopathy. Nat Rev Cardiol 7(4):187–193PubMedCrossRef
69.
Hurst RT, Prasad A, Askew JW 3rd, Sengupta PP, Tajik AJ (2010) Takotsubo cardiomyopathy: a unique cardiomyopathy with variable ventricular morphology. JACC Cardiovasc Imaging 3(6):641–649PubMedCrossRef
70.
Medeiros K, O'Connor MJ, Baicu CF, Fitzgibbons TP, Shaw P, Tighe DA et al (2014) Systolic and diastolic mechanics in stress cardiomyopathy. Circulation 129(16):1659–1667PubMedCrossRef
71.
Pilgrim TM, Wyss TR (2008) Takotsubo cardiomyopathy or transient left ventricular apical ballooning syndrome: a systematic review. Int J Cardiol 124(3):283–292PubMedCrossRef
72.
Kawai S, Kitabatake A, Tomoike H (2007) Guidelines for diagnosis of takotsubo (ampulla) cardiomyopathy. Circ J 71(6):990–992PubMedCrossRef
73.
Bybee KA, Prasad A, Barsness GW, Lerman A, Jaffe AS, Murphy JG et al (2004) Clinical characteristics and thrombolysis in myocardial infarction frame counts in women with transient left ventricular apical ballooning syndrome. Am J Cardiol 94(3):343–346PubMedCrossRef
74.
Kurisu S, Inoue I, Kawagoe T, Ishihara M, Shimatani Y, Nakamura S et al (2004) Time course of electrocardiographic changes in patients with tako-tsubo syndrome: comparison with acute myocardial infarction with minimal enzymatic release. Circ J 68(1):77–81PubMedCrossRef
75.
Conwell LS, Gray LM, Delbridge RG, Thomsett MJ, Batch JA (2003a) Reversible cardiomyopathy in paediatric Addison's disease--a cautionary tale. J Pediatr Endocrinol Metab 16(8):1191–1195PubMedCrossRef
76.
Khalid N, Chhabra L, Ahmad SA, Umer A, Spodick DH (2015) Case report: autoimmune Polyglandular syndrome type 2 complicated by acute adrenal crisis and pericardial tamponade in the setting of Normal thyroid function. Methodist Debakey Cardiovasc J 11(4):250–252PubMedPubMedCentralCrossRef
77.
Torfoss D (1998) Cardiac tamponade preceding adrenal insufficiency – an unusual presentation of Addison's disease. J Intern Med 243(5):399–400CrossRef
78.
Algün E, Erkoç R, Kotan C, Güler N, Sahin I, Ayakta H et al (2001) Polyserositis as a rare component of polyglandular autoimmune syndrome type II. Int J Clin Pract 55(4):280–281PubMedCrossRef
79.
Alkaabi JM, Chik CL, Lewanczuk RZ (2008) Pericarditis with cardiac tamponade and addisonian crisis as the presenting features of autoimmune polyglandular syndrome type II: a case series. Endocr Pract 14(4):474–478PubMedCrossRef
80.
Tucker WS Jr, Niblack GD, McLean RH, Alspaugh MA, Wyatt RJ, Jordan SC et al (1987) Serositis with autoimmune endocrinopathy: clinical and immunogenetic features. Medicine (Baltimore) 66(2):138–147PubMedCrossRef
81.
Taxter AJ, Bellin MD, Binstadt BA (2011) Pericarditis as the presenting feature of adrenoleukodystrophy. Pediatrics 127(3):e777–e780CrossRef
82.
Traficante G, Biagiotti R, Andreucci E, Di Tommaso M, Provenzano A, Cariati E, Giglio S (2015) Prenatal diagnosis of X-linked adrenoleukodystrophy associated with isolated pericardial effusion. Clin Case Rep 3(7):643–645PubMedPubMedCentralCrossRef
83.
Kawahara J, Shinozaki Y, Takata H, Katsuta S, Kawane T, Hiraiwa Y (2016) A case of tuberculous Addison disease with recurrent nontuberculous pericarditis. AACE Clin Case Rep 2(3):e199–e201CrossRef
84.
Wani AI, Farooqui KJ, Bashir MI, Mir SA, Lone AA, Masoodi SR (2013a) Autoimmune polyglandular syndrome type 1 with reversible dilated cardiomyopathy: complete recovery after correction of hypocalcemia and hypocortisolemia. J Pediatr Endocrinol Metab 26(3–4):373–376PubMed
85.
Wiltshire EJ, Wilson R, Pringle KC (2004a) Addison's disease presenting with an acute abdomen and complicated by cardiomyopathy. J Paediatr Child Health 40(11):644–645PubMedCrossRef
86.
Erichsen MM, Løvås K, Skinningsrud B, Wolff AB, Undlien DE, Svartberg J et al (2009c) Clinical, immunological, and genetic features of autoimmune primary adrenal insufficiency: observations from a Norwegian registry. J Clin Endocrinol Metab 94(12):4882–4890PubMedCrossRef
87.
Bornstein SR, Allolio B, Arlt W, Barthel A, Don-Wauchope A, Hammer GD et al (2016b) Diagnosis and treatment of primary adrenal insufficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 101(2):364–389PubMedCrossRef
88.
Stewart PM, Biller BMK, Marelli C, Gunnarsson C, Ryan MP, Johannsson G (2016) Exploring inpatient hospitalizations and morbidity in patients with adrenal insufficiency. J Clin Endocrinol Metab 101(12):4843–4850PubMedCrossRef
Metadata
Title
Adrenal crisis-induced cardiogenic shock (ACCS): a comprehensive review
Authors
Maryam Heidarpour
Davood Shafie
Reza Eshraghi
Seyed Reza Mirjalili
Ashkan Bahrami
Mohammad Reza Movahed
Publication date
06-11-2024
Publisher
Springer US
Published in
Heart Failure Reviews
Print ISSN: 1382-4147
Electronic ISSN: 1573-7322
DOI
https://doi.org/10.1007/s10741-024-10458-y

Keynote series | Spotlight on menopause

Menopause can have a significant impact on the body, with effects ranging beyond the endocrine and reproductive systems. Learn about the broader systemic effects of menopause, so you can help patients in your clinics through the transition.

Launching: Thursday 12th December 2024
 

Prof. Martha Hickey
Dr. Claudia Barth
Dr. Samar El Khoudary
Developed by: Springer Medicine
Register your interest now

A quick guide to ECGs

Improve your ECG interpretation skills with this comprehensive, rapid, interactive course. Expert advice provides detailed feedback as you work through 50 ECGs covering the most common cardiac presentations to ensure your practice stays up to date. 

PD Dr. Carsten W. Israel
Developed by: Springer Medizin
Start the cases

Keynote webinar | Spotlight on medication adherence

  • Webinar | 27-06-2024 | 18:00 (CEST)

Medication non-adherence is a major barrier to effective healthcare delivery; half of all patients do not follow their doctor’s recommendations or treatment plan.

Our experts explain the fundamentals with a practical discussion of how to manage non-adherence in two common scenarios: hypertension and asthma control.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Watch now
Image Credits